Home | All results_reference

[RDF data]
Results Reference #1250

Resource URI: http://static.linkedct.org/resource/results_reference/1250
linkedct:citation Moulder SL, Wang M, Gradishar W, et al.: A phase II trial of trastuzumab, weekly ixabepilone and carboplatin (TIC) in patients with HER2/neu-positive (HER2+) metastatic breast cancer (MBC): a trial coordinated by the Eastern Cooperative Oncology Group (E2103). [Abstract] American Society of Clinical Oncology 2007 Breast Cancer Symposium, 7-8 September 2007, San Francisco, California A-152, 2007.
rdfs:label Results Reference #1250
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00077376>
linkedct:results_reference_id 1250 (xsd:int)
rdf:type linkedct:results_reference